Skip to main content
Premium Trial:

Request an Annual Quote

Scripps Joins Primary Human Tumor Consortium

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Scripps Translational Science Institute has joined the Primary Human Tumor Consortium, an effort to build a library of primary human tumors, Jackson Laboratory announced this week.

The goal of PHTC, which is being headed by Jackson Lab, is to develop highly targeted cancer therapies.

Scripps will provide solid human tumor samples to Jackson Lab, which will graft them into mouse models. Jackson Lab will perform the initial genomic characterization of the tumors and share the data with other participating institutions of PHTC. They include the University of Florida, the Swedish Neuroscience Institute in Seattle, and the University of California, Davis Cancer Center.

"By joining this consortium, Scripps will contribute to and share in a tumor library that will vastly exceed what any institution could build on its own," Nicholas Schork, director of bioinformatics and biostatistics at Scripps, said in a statement. "This shared resource ultimately will greatly expand research capacity for all consortium members, with the goal of accelerating drug development for individualized approaches to each type of tumor."

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.